Axsome Therapeutics IPO Research Information

Axsome Therapeutics IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Axsome Therapeutics, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Axsome Therapeutics	AXSM - NASDAQ	$11.00-$13.00	$9.00	$9.00	5.6 million	11/19/2015
Underwriter(s): Ladenburg Thalmann
Co-Manager(s): Cantor Fitzgerald & Co., Brean Capital
Industry: Health Care
Filing(s): Filed 2015-10-13 Terms Added 2015-11-02

Axsome Therapeutics Quote & Chart - Click for current quote - AXSM

About Axsome Therapeutics (adapted from Axsome Therapeutics prospectus):
They are a clinical stage biopharmaceutical company developing novel therapies for the management of pain and other central nervous system, or CNS, disorders.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "AXSM" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.